Acelyrin Raises $540M In IPO, Stock Gains Over 20% In Trading Debut
Acelyrin Inc (NASDAQ: SLRN), a late-stage clinical biopharma company, started trading today and opened at $23/share compared to IPO
Actelis Networks Announces $3.5M Private Placement For The Purchase And Sale Of 944,670 Shares Of Its Common Stock And Warrants Priced At $3.705/Share And 3.58/Warrant Price Of At-The-Market Under Nasdaq Rules
Actelis Networks, Inc. (NASDAQ:ASNS) ("Actelis" or the "Company") a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced that it has
Privia Health Announces Upsized Pricing Of Secondary Offering Of $936M Of 42,561,196 Shares Of Common Stock At A Price Of $22/Share
Privia Health Group, Inc. (NASDAQ:PRVA), a technology-driven, national physician enablement company, today announced the upsized pricing of an underwritten secondary offering of 42,561,196 shares of common stock by
Mawson Infrastructure Group Inc. Announces $5M Registered Direct Offering
Mawson Infrastructure Group Inc. (NASDAQ:MIGI) ("Mawson" or the "Company"), a digital infrastructure provider, today announced a $5 million registered direct offering.
Mawson has entered
Reneo Pharmaceuticals Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed
Reneo Pharmaceuticals, Inc. (Reneo) (NASDAQ:RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today
MeiraGTx Announces $60M Private Placement Of 10.7M Ordinary Shares At A Price Of $5.75/Share
MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it has agreed to sell approximately 10.7 million ordinary shares at a price of $5.75 per share.
Why Guardforce AI Shares Are Plunging Today
Guardforce AI Co Ltd (NASDAQ:GFA) shares are plunging Wednesday premarket as it priced an underwritten public offering of 1.72 million ordinary…
Morphic Therapeutic Raises $240M Via Secondary Share Sale Of 5.3M Shares At $45.00 Per Share
Morphic Holding, Inc. (NASDAQ:MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, today announced the pricing of an underwritten public
Guardforce AI Stock Is Tanking After Hours: What’s Going On?
Guardforce AI Co (NASDAQ: GFAI) shares are plunging in Tuesday's after-hours session after the company proposed an offering.